DE69805831D1 - 1,4-disubstituierte cyclohexan-derivate als liganden der 5ht1a rezeptoren - Google Patents

1,4-disubstituierte cyclohexan-derivate als liganden der 5ht1a rezeptoren

Info

Publication number
DE69805831D1
DE69805831D1 DE69805831T DE69805831T DE69805831D1 DE 69805831 D1 DE69805831 D1 DE 69805831D1 DE 69805831 T DE69805831 T DE 69805831T DE 69805831 T DE69805831 T DE 69805831T DE 69805831 D1 DE69805831 D1 DE 69805831D1
Authority
DE
Germany
Prior art keywords
triazine
cyclohexane derivatives
concerns
ligands
dioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69805831T
Other languages
English (en)
Other versions
DE69805831T2 (de
Inventor
Jean-Francois Patoiseau
Elisabeth Dupont-Passelaigue
Wouter Koek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Application granted granted Critical
Publication of DE69805831D1 publication Critical patent/DE69805831D1/de
Publication of DE69805831T2 publication Critical patent/DE69805831T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69805831T 1997-10-16 1998-10-14 1,4-disubstituierte cyclohexan-derivate als liganden der 5ht1a rezeptoren Expired - Lifetime DE69805831T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9712954A FR2769913B1 (fr) 1997-10-16 1997-10-16 Nouveaux derives cyclohexaniques difonctionnalises en 1, 4, leur preparation et leur application therapeutique humaine
PCT/FR1998/002207 WO1999020613A1 (fr) 1997-10-16 1998-10-14 Derives cyclohexaniques difonctionnalises en 1,4, en tant que ligands des recepteurs 5ht1a

Publications (2)

Publication Number Publication Date
DE69805831D1 true DE69805831D1 (de) 2002-07-11
DE69805831T2 DE69805831T2 (de) 2003-01-23

Family

ID=9512297

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805831T Expired - Lifetime DE69805831T2 (de) 1997-10-16 1998-10-14 1,4-disubstituierte cyclohexan-derivate als liganden der 5ht1a rezeptoren

Country Status (14)

Country Link
US (1) US6191130B1 (de)
EP (1) EP1023273B1 (de)
JP (1) JP4454848B2 (de)
CN (1) CN1127490C (de)
AT (1) ATE218553T1 (de)
AU (1) AU737178B2 (de)
BR (1) BR9812939B1 (de)
CA (1) CA2306429C (de)
DE (1) DE69805831T2 (de)
DK (1) DK1023273T3 (de)
ES (1) ES2177064T3 (de)
FR (1) FR2769913B1 (de)
PT (1) PT1023273E (de)
WO (1) WO1999020613A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11307553A (ja) * 1998-04-21 1999-11-05 Shinkawa Ltd 半導体ペレットの位置決め方法及びその装置
PA8802101A1 (es) * 2007-11-02 2009-08-26 Abbott Gmbh & Co Kg Compuestos de 1,2,4-3,5-diona adecuados para el tratamiento de trastornos que responden a la modulación del receptor de dopamina d3
GB201017345D0 (en) * 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
WO2014025993A1 (en) * 2012-08-08 2014-02-13 The Johns Hopkins University Inhibitors of d-amino acid oxidase
ES2826558T3 (es) 2015-04-02 2021-05-18 Proximagen Llc Nuevas terapias para el cáncer
CN111454250B (zh) * 2019-01-21 2021-05-07 华东理工大学 多靶点活性化合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707294B1 (fr) * 1993-07-06 1995-09-29 Pf Medicament Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
FR2727682A1 (fr) * 1994-12-02 1996-06-07 Pf Medicament Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament

Also Published As

Publication number Publication date
FR2769913A1 (fr) 1999-04-23
AU9545898A (en) 1999-05-10
US6191130B1 (en) 2001-02-20
ES2177064T3 (es) 2002-12-01
DK1023273T3 (da) 2002-09-30
DE69805831T2 (de) 2003-01-23
EP1023273B1 (de) 2002-06-05
BR9812939A (pt) 2000-08-08
PT1023273E (pt) 2002-10-31
EP1023273A1 (de) 2000-08-02
CN1127490C (zh) 2003-11-12
AU737178B2 (en) 2001-08-09
JP4454848B2 (ja) 2010-04-21
CA2306429C (fr) 2010-03-30
FR2769913B1 (fr) 2000-03-10
JP2001520223A (ja) 2001-10-30
ATE218553T1 (de) 2002-06-15
BR9812939B1 (pt) 2009-12-01
CN1278800A (zh) 2001-01-03
CA2306429A1 (fr) 1999-04-29
WO1999020613A1 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
NO2012021I1 (no) Perampanel eller salter eller hydrater derav
EA200000096A1 (ru) Производные арилоксиарилсульфониламиногидроксамовой кислоты
NO20023456D0 (no) Nitrogenholdige forbindelser og farmasöytiske preparater inneholdende de samme
DE69201058T2 (de) Perhydroisoindol derivate und ihre herstellung.
CO5640098A2 (es) Acidos biariloximetilaren-carboxilicos
ATE190052T1 (de) Thiazolidindione-derivate, ihre herstellung und verwendung
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
EA199901062A1 (ru) Производные хинолин-4-карбоксамида как антагонисты рецепторов нк-2 и нк-3
MY137761A (en) The use of n-arylhdrazine derivatives for combating non-crop pests
ATE237612T1 (de) Benzofuranderivate
ATE218553T1 (de) 1,4-disubstituierte cyclohexan-derivate als liganden der 5ht1a rezeptoren
TNSN88031A1 (fr) Procede pour l'obtention de derives aromatiques ayant une activite antimicrobienne
DK1209151T3 (da) 4-substituerede piperidinderivativer
GB2311780A (en) Piperazine-2,5-dione derivatives as modulators of multidrug resistance
NO974588D0 (no) Triazol-antifungaltmiddel
NZ505596A (en) Fungicidal mixtures based on amide compounds and morpholine or piperidine derivatives
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
FI962768A0 (fi) N-(2-ftaali-imidoetyyli)substituoituja transpiperidiini-2,5-dikarboksylaatteja
RS50791B (sr) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
ATE448198T1 (de) Neue alpha-ketoamidderivate und deren verwendung
CO4761068A1 (es) Nuevos antagonistas nk-2/nk-3
ATE462689T1 (de) Vitamin-d-derivate mit substituenten an der 2- alpha-position
PT1214312E (pt) Indoles 5-aminoalquilo e 5-aminocarbonilo substituidos
CO4750832A1 (es) Nuevos derivados de quinolina
ECSP982510A (es) Nuevos compuestos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition